Zydus Wellness Limited (NSE:ZYDUSWELL)
India · Delayed Price · Currency is INR | Market Cap | 161.23B +38.4% |
| Revenue (ttm) | 39.61B +46.2% |
| Net Income | 1.97B -43.2% |
| EPS | 6.20 -43.1% |
| Shares Out | n/a |
| PE Ratio | 81.76 |
| Forward PE | 36.59 |
| Dividend | 1.20 (0.24%) |
| Ex-Dividend Date | Jul 17, 2026 |
| Volume | 246,206 |
| Open | 502.45 |
| Previous Close | 501.45 |
| Day's Range | 492.60 - 511.00 |
| 52-Week Range | 367.55 - 552.40 |
| Beta | -0.07 |
| Analysts | Buy |
| Price Target | 564.29 (+12.19%) |
| Earnings Date | May 18, 2026 |
About Zydus Wellness
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I’m lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, fa... [Read more]
Financial Performance
In fiscal year 2026, Zydus Wellness's revenue was 39.61 billion, an increase of 46.22% compared to the previous year's 27.09 billion. Earnings were 1.97 billion, a decrease of -43.15%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for ZYDUSWELL stock is "Buy." The 12-month stock price target is ₹564.29, which is an increase of 12.19% from the latest price.
News
Zydus Wellness reports acquisition of 4,000 equity shares by insider
Zydus Wellness Limited has disclosed the acquisition of 4,000 equity shares by Ms. Rupa Nitinkumar Parekh, the spouse of Mr. Nitinkumar Parekh, a designated person within the company. This transaction...
Zydus Wellness reports transmission of 10,000 equity shares within promoter group
Zydus Wellness Limited has disclosed a transmission of 10,000 equity shares within its promoter group. The shares were transferred to Mr. Samar Babubhai Patel, a member of the promoter group,…
Top stocks to buy: Stock recommendations for May 25, 2026 week - check list
Stock market recommendations: Samvardhana Motherson, and Zydus Wellness have been recommended as top stocks to buy for the week starting May 25, 2026 by Motilal Oswal Wealth Management Research Desk:
Zydus Wellness confirms compliance with SEBI regulations for FY 2026
Zydus Wellness Limited has successfully adhered to the regulatory requirements set by the Securities and Exchange Board of India (SEBI) for the financial year ending 31st March 2026. This was…
Zydus Wellness Transcript: Q4 25/26
Q4 FY 2026 saw strong sales growth driven by international expansion, innovation, and digital channels, though net profit was impacted by exceptional items and amortization. Seasonal brands underperformed due to weather, but non-seasonal and new segments delivered robust growth.
Zydus Wellness Quarterly report: Q4 2026
Zydus Wellness has published its Q4 2026 quarterly earnings report on May 18, 2026.
Zydus Wellness Slides: Q4 2026
Zydus Wellness has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.
Zydus Wellness reports 62.1% net sales growth for Q4 FY26
Zydus Wellness Limited has reported a significant 62.1% increase in net sales for the fourth quarter of FY26, reaching ₹14,761 million compared to ₹9,106 million in the same period last…
Zydus Wellness Q4 Results: Net profit slips YoY on margin hit, revenue higher by 63%
Zydus Wellness reported a 5.8% year-on-year decline in net profit for the fourth quarter, even as revenue and operating performance saw strong growth during the period. The company posted a…
Zydus Wellness shares surge 8.85% on April 13: Details here
Shares of Zydus Wellness Limited surged 8.85% on April 13, trading against the broader market trend during the session and touching a fresh 52-week high. The stock opened at ₹489.00…
Zydus Wellness shares surge over 18% today: Details here
Shares of Zydus Wellness Limited surged 18.43% on April 6, trading against the broader market trend during the session. The stock opened at ₹447.55 against its previous close of ₹443.05,…
Zydus Wellness subsidiary faces EUR 19,472.57 penalty from Spanish Tax Authority
Zydus Wellness Limited has announced that its step-down wholly owned subsidiary, Comfort Click Limited (CCL) in the United Kingdom, has been issued a penalty by the Spanish Tax Authority. The…
Zydus Wellness faces ₹6.30 million penalty over GST input tax credit issue
Zydus Wellness Limited, through its wholly owned subsidiary Zydus Wellness Products Limited (ZWPL), has been issued a penalty of ₹6.30 million by the Office of the Assistant Commissioner, Division-II,...
Zydus Wellness sees acquisition of 1,500 equity shares by designated person
Zydus Wellness Limited has reported an acquisition of 1,500 equity shares by Mr. Rinesh Gajjar, a designated person within the company. The transaction, valued at ₹6,04,443.15, was executed through th...
Why Zydus Wellness shares surge over 3% today? Explained
Shares of Zydus Wellness Limited surged more than 3% in early trade on Monday, March 16, as investors reacted positively to the company’s strong push towards sustainable manufacturing and energy…
Why are Zydus Wellness shares up over 13% today? Key reason explained
Shares of Zydus Wellness surged sharply in Friday’s trading session, rising more than 13% intraday as strong buying interest and heavy volumes pushed the stock higher. As of 12:47 PM…
Zydus Wellness designated persons acquire shares worth Rs 7.78 lakh in open market trades
Three designated persons at Zydus Wellness acquired equity shares through open market transactions on the National Stock Exchange between March 2 and March 9, 2026. Vineet Shrivastava purchased 787 eq...
Zydus Wellness Transcript: Q3 25/26
Q3 FY26 saw 113.7% sales growth, driven by food and nutrition, Comfort Click integration, and strong e-commerce momentum. Gross margin rose to 63%, EBITDA margin to 6.3%, but net loss persisted due to acquisition-related costs. Margin and growth improvements are expected in FY27.
Zydus Wellness Quarterly report: Q3 2026
Zydus Wellness has published its Q3 2026 quarterly earnings report on February 3, 2026.
Zydus Wellness Slides: Q3 2026
Zydus Wellness has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 3, 2026.
Zydus Wellness Transcript: Q2 25/26
Consolidated sales grew 31% for the quarter, driven by the Comfort Click acquisition and resilient non-seasonal brands, while seasonal brands faced weather-related headwinds. EBITDA rose 17.3% year-over-year, with management reaffirming a 17-18% EBITDA margin target over two years.
Zydus Wellness Quarterly report: Q2 2026
Zydus Wellness has published its Q2 2026 quarterly earnings report on November 5, 2025.
Zydus Wellness Slides: Q2 2026
Zydus Wellness has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 5, 2025.
Top Q2 results today, November 5: Aurobindo Pharma, Blue Star, Delhivery, Zydus Wellness more to announce earnings
The corporate earnings season for the July–September quarter (Q2 FY2025–26) continues in full swing, with more than 100 listed companies...
Zydus Wellness says GST cut to 5% will boost demand for key brands like Complan, Glucon-D, SugarFree
Zydus Wellness Limited has welcomed the government’s latest GST reform, calling it a “Diwali gift” for consumers, as several of its flagship brands will now attract a lower tax rate. In a regulatory f...